What’s Happening: CHA submitted comments to the Food & Drug Administration (FDA) on proposed regulation of laboratory developed tests (LDTs).
What Else to Know: The proposed rule would have significant unintended consequences for the delivery of medical laboratory services and would raise costs to the overall health care system.
This content is restricted to members.
